465 related articles for article (PubMed ID: 15327601)
1. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
[No Abstract] [Full Text] [Related]
2. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
Tuohy JF; Sangalli M; Kim L
Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
[TBL] [Abstract][Full Text] [Related]
4. Costs and benefits of non-invasive fetal RhD determination.
Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
6. [Weak D (Du) phenotype and pregnancy].
Stefanova A
Akush Ginekol (Sofiia); 2005; 44(1):54-6. PubMed ID: 15853015
[No Abstract] [Full Text] [Related]
7. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
8. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
Poissonnier MH
J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
[No Abstract] [Full Text] [Related]
9. Antenatal Rh prophylaxis is unnecessary for "Asia type" DEL women.
Shao CP; Xu H; Xu Q; Sun GD; Li JP; Zhang BW; Liang XH; Liu Z; Zhou Y; Li D; Zhuang NB
Transfus Clin Biol; 2010 Oct; 17(4):260-4. PubMed ID: 20961786
[TBL] [Abstract][Full Text] [Related]
10. [Is it always necessary to give anti-D gamma-globulins in the case of spontaneous miscarriage in Rhesus-negative patients?].
Salvat J; Slamani L; Capilna M; Brescu O
Contracept Fertil Sex; 1997 Apr; 25(4):V-IX. PubMed ID: 9229512
[No Abstract] [Full Text] [Related]
11. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
12. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
Sainio S; Kuosmanen M
Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
[TBL] [Abstract][Full Text] [Related]
13. Anti-D guidelines.
Kanjilal K; Tasker M
Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
[No Abstract] [Full Text] [Related]
14. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
15. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
16. [Rhesus prophylaxis--history and current status].
Behrens O; Lellé RJ
Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
[TBL] [Abstract][Full Text] [Related]
17. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
[No Abstract] [Full Text] [Related]
18. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
[No Abstract] [Full Text] [Related]
19. RhD negative women. Are we ready to change practice?
Wray J
Pract Midwife; 2000 Oct; 3(9):26-8. PubMed ID: 12026547
[No Abstract] [Full Text] [Related]
20. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
